Single-Use Bioreactors Unwrap Commercial Manufacturing Options

Publication
Article
BioPharm InternationalBioPharm International-06-15-2019
Volume 2019 eBook
Issue 2
Pages: 24–27

This article provides a review of various 2000-L single-use bioreactors used by biopharmaceutical suppliers for commercial production.

Several companies have invested in 2000-L single-use bioreactors to expand production capabilities, including Thermo Fisher Scientific, GE Healthcare, Pall Biotech, and Sartorius Stedim Biotech. This article highlights the features, functions, and capacities of several large-volume bioreactors by these companies that are used in the market today.

Read this article in BioPharm International's Single-Use Systems 2019 eBook.

Article Details

BioPharm International
eBook: Single-Use Systems 2019
Vol. 32
June 2019
Pages: 24–27

Citation

When referring to this article, please cite it as A. Lowry, "Single-Use Bioreactors Unwrap Commercial Manufacturing Options," BioPharm International Single-Use Systems eBook (June 2019).

Recent Videos
William K. Oh, MD
Adam Sherlock, CEO of Qinecsa, discusses the changing political landscapes in the US and Europe and how that may affect the bio/pharma industry.
Adam Sherlock, CEO of Qinecsa Solutions
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
© 2025 MJH Life Sciences

All rights reserved.